- €9.49bn
- €9.62bn
- €1.89bn
Brief: Orion To Provide MSD Global Exclusive Rights To Opevesostat
Brief: Orion Participates In Project Led By University Of Turku
FY EBIT outlook upgrade lifts Orion shares
Brief: Orion Says Strikes Did Not Have Material Impact In Q1
Brief: Orion Q1 Operating Profit EUR 56 Million Vs. Estimate EUR 57.3 Million
Earnings Poll: Orion Oyj first quarter results due on April 25
Brief: Orion To Continue To Explore Outsourcing In Kuopio
Bayer says 2024 sales of prostate cancer drug above $1 bln
Top of the Street: Orion, Nibe, Hiscox
Jefferies downgrades Orion on Nubeqa 'over-reliance'
Europe Research Roundup: Allianz SE, Halma, ITM Power Plc
Brief: Orion Investigates Possible Outsourcing Of Pharmaceutical Production In Kuopio
Orion drops to bottom of STOXX on worse-than expected Q4 EBIT, outlook
Brief: Orion Proposes Dividend Of EUR 1.62 Per Share For 2023
Brief: Orion Q4 Operating Profit EUR 92.9 Million Vs. Estimate EUR 73 Million
Earnings Poll: Orion Oyj fourth quarter results due on February 13
Brief: Orion, Newel Health Enter Into Licensing Agreement
Brief: Orion Appoints René Lindell As CFO
Brief: Orion Appoints René Lindell Appointed As CFO